Compound ID | 955
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Stable to a wide range of beta-lactamases |
| Target Pathogen: | Active against Pseudomonas aeruginosa |
| Description: | A carboxypenam; 1. Ochiai H, Murotani Y, Yamamoto H, et al. Novel parenteral 2-carboxypenas, T-5575 and T-5578. I. Synthesis and structure-activity relationships of 2-carboxypenam derivatives. 32nd-Intersci-Conf-Antimicrobial-Agents-Chemother 1992; 174 2. Watanabe Y, Minami S, Hayashi T, et al. Novel parenteral 2-carboxypenams, T-5575 and T-5578. II. In vitro and In vivo biological properties. 32nd-Intersci-Conf-Antimicrobial-Agents-Chemother 1992; 175 |
| Institute where first reported: | Toyama Chemical Co. Japan |
| Year first mentioned: | 1992 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/129651151 |